Lennham Pharmaceuticals Announces Issuance of U.S. Patent Covering Methods of Administering Psilocybin and Psilocin

Read more here.

Next
Next

Lennham publishes manuscript detailing the nonclinical PK and safety evaluation of d9-caffeine in Food and Chemical Toxicology